Transcriptomics of CD8 T cells and Immune Checkpoint Blockade

benjamin.fairfax@oncology.ox.ac.uk

Request Access

Dataset ID	Description	Technology	Samples
EGAD00001005973	We are interested in inter-individual variation in transcriptional response to immune checkpoint blockade. We have analysed poly A purified RNA expression from CD8 T cells (297 transcriptomes in total) isolated from metastatic melanoma patients (n=106) prior to and during treatment with either single agent (Pembrolizumab) or combination (Ipilimumab/ Nivolumab) immune checkpoint blockade. We compare expression at different stages of treatment and additionally contrast this with that from healthy controls (n=68).	Illumina HiSeq 4000	297